Beranda22Z • ETR
add
Zealand Pharma A/S
Tutup sebelumnya
€54,88
Rentang hari
€55,12 - €56,04
Rentang tahun
€52,36 - €73,90
Kapitalisasi pasar
29,32 M DKK
Volume Rata-Rata
563,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
CPH
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (DKK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 49,57 jt | 1.022,74% |
Biaya operasional | 510,89 jt | 42,98% |
Penghasilan bersih | -404,23 jt | -51,74% |
Margin laba bersih | -815,50 | 86,48% |
Penghasilan per saham | -5,75 | -52,52% |
EBITDA | -454,10 jt | -33,52% |
Tarif pajak efektif | -10,23% | — |
Neraca
Total aset
Total liabilitas
| (DKK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 16,17 M | 90,65% |
Total aset | 16,80 M | 74,43% |
Total liabilitas | 1,63 M | 118,92% |
Total ekuitas | 15,16 M | — |
Saham yang beredar | 70,29 jt | — |
Harga terhadap nilai buku | 0,25 | — |
Tingkat pengembalian aset | -6,79% | — |
Tingkat pengembalian modal | -7,30% | — |
Arus Kas
Perubahan kas bersih
| (DKK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -404,23 jt | -51,74% |
Kas dari operasi | -443,77 jt | -50,26% |
Kas dari investasi | -855,43 jt | 85,92% |
Kas dari pembiayaan | -78,28 jt | 71,25% |
Perubahan kas bersih | -1,27 M | 80,87% |
Arus kas bebas | -257,65 jt | -9,03% |
Tentang
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Didirikan
1 Apr 1997
Situs
Karyawan
440
